Deal Spotlight
July 12, 2026
Resilience raises €414M Series D with 8VC/Joe Lonsdale
€414M
round size
series-d
stage
The funding round closed on June 24, 2026, with 8VC/Joe Lonsdale participating as the lead investor. The company has raised a total of €616.4M to date across two rounds.
Resilience is a technology-focused biomanufacturing company in the Healthcare & Life Sciences sector. It provides services ranging from cell and gene therapy to vaccines and biologics. The company is based in the United States and is at the series-c-plus stage.
Related insights
- Cross-Country AnalysisFinance & Blockchain's 6.2pp decline cedes ground to Energy, Environment & Mobility's 1.9pp gain
- Cross-Country AnalysisUS startups advance from Series A to B 21% faster than UK peers
- Cross-Country AnalysisCommerce seed funding share drops 6.6pp, ceded to Energy's 4.3pp rise
- Deal SpotlightRepodo raises €8.2M with Hedosophia and Seed Capital participating
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.